Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158483816> ?p ?o ?g. }
- W2158483816 endingPage "1480" @default.
- W2158483816 startingPage "1473" @default.
- W2158483816 abstract "Background Aberrant activation of tyrosine kinases, caused by either mutation or gene fusion, is of major importance for the development of many hematologic malignancies, particularly myeloproliferative neoplasms. We hypothesized that hitherto unrecognized, cytogenetically cryptic tyrosine kinase fusions may be common in non-classical or atypical myeloproliferative neoplasms and related myelodysplastic/myeloproliferative neoplasms.Design and Methods To detect genomic copy number changes associated with such fusions, we performed a systematic search in 68 patients using custom designed, targeted, high-resolution array comparative genomic hybridization. Arrays contained 44,000 oligonucleotide probes that targeted 500 genes including all 90 tyrosine kinases plus downstream tyrosine kinase signaling components, other translocation targets, transcription factors, and other factors known to be important for myelopoiesis.Results No abnormalities involving tyrosine kinases were detected; however, nine cytogenetically cryptic copy number imbalances were detected in seven patients, including hemizygous deletions of RUNX1 or CEBPA in two cases with atypical chronic myeloid leukemia. Mutation analysis of the remaining alleles revealed non-mutated RUNX1 and a frameshift insertion within CEBPA. A further mutation screen of 187 patients with myelodysplastic/myeloproliferative neoplasms identified RUNX1 mutations in 27 (14%) and CEBPA mutations in seven (4%) patients. Analysis of other transcription factors known to be frequently mutated in acute myeloid leukemia revealed NPM1 mutations in six (3%) and WT1 mutations in two (1%) patients with myelodysplastic/myeloproliferative neoplasms. Univariate analysis indicated that patients with mutations had a shorter overall survival (28 versus 44 months, P=0.019) compared with patients without mutations, with the prognosis for cases with CEBPA, NPM1 or WT1 mutations being particularly poor.Conclusions We conclude that mutations of transcription and other nuclear factors are frequent in myelodysplastic/myeloproliferative neoplasms and are generally mutually exclusive. CEBPA, NPM1 or WT1 mutations may be associated with a poor prognosis, an observation that will need to be confirmed by detailed prospective studies." @default.
- W2158483816 created "2016-06-24" @default.
- W2158483816 creator A5005750354 @default.
- W2158483816 creator A5005760956 @default.
- W2158483816 creator A5021124944 @default.
- W2158483816 creator A5031327122 @default.
- W2158483816 creator A5035964802 @default.
- W2158483816 creator A5036839901 @default.
- W2158483816 creator A5038048953 @default.
- W2158483816 creator A5039765871 @default.
- W2158483816 creator A5066180617 @default.
- W2158483816 creator A5068291978 @default.
- W2158483816 creator A5069571779 @default.
- W2158483816 date "2010-04-26" @default.
- W2158483816 modified "2023-10-16" @default.
- W2158483816 title "Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms" @default.
- W2158483816 cites W1524505355 @default.
- W2158483816 cites W1600695244 @default.
- W2158483816 cites W1963966940 @default.
- W2158483816 cites W1965113891 @default.
- W2158483816 cites W1977041541 @default.
- W2158483816 cites W1981125188 @default.
- W2158483816 cites W1986389204 @default.
- W2158483816 cites W1994951654 @default.
- W2158483816 cites W2007375261 @default.
- W2158483816 cites W2007836133 @default.
- W2158483816 cites W2009465244 @default.
- W2158483816 cites W2012952884 @default.
- W2158483816 cites W2013726626 @default.
- W2158483816 cites W2015157349 @default.
- W2158483816 cites W2025391163 @default.
- W2158483816 cites W2025645148 @default.
- W2158483816 cites W2026310796 @default.
- W2158483816 cites W2027613124 @default.
- W2158483816 cites W2034573434 @default.
- W2158483816 cites W2034817767 @default.
- W2158483816 cites W2035543326 @default.
- W2158483816 cites W2039234691 @default.
- W2158483816 cites W2043216151 @default.
- W2158483816 cites W2068158468 @default.
- W2158483816 cites W2073872690 @default.
- W2158483816 cites W2077784268 @default.
- W2158483816 cites W2082312262 @default.
- W2158483816 cites W2092194090 @default.
- W2158483816 cites W2097743943 @default.
- W2158483816 cites W2100088478 @default.
- W2158483816 cites W2103012849 @default.
- W2158483816 cites W2106473110 @default.
- W2158483816 cites W2107398329 @default.
- W2158483816 cites W2108804284 @default.
- W2158483816 cites W2116753165 @default.
- W2158483816 cites W2118072401 @default.
- W2158483816 cites W2126665281 @default.
- W2158483816 cites W2132749685 @default.
- W2158483816 cites W2133283496 @default.
- W2158483816 cites W2136651434 @default.
- W2158483816 cites W2137573050 @default.
- W2158483816 cites W2138914369 @default.
- W2158483816 cites W2148033929 @default.
- W2158483816 cites W2154725061 @default.
- W2158483816 cites W2156439133 @default.
- W2158483816 cites W2161407778 @default.
- W2158483816 cites W2170515966 @default.
- W2158483816 cites W2325615840 @default.
- W2158483816 cites W2610334482 @default.
- W2158483816 cites W2147221248 @default.
- W2158483816 doi "https://doi.org/10.3324/haematol.2010.021808" @default.
- W2158483816 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2930947" @default.
- W2158483816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20421268" @default.
- W2158483816 hasPublicationYear "2010" @default.
- W2158483816 type Work @default.
- W2158483816 sameAs 2158483816 @default.
- W2158483816 citedByCount "62" @default.
- W2158483816 countsByYear W21584838162012 @default.
- W2158483816 countsByYear W21584838162013 @default.
- W2158483816 countsByYear W21584838162014 @default.
- W2158483816 countsByYear W21584838162015 @default.
- W2158483816 countsByYear W21584838162016 @default.
- W2158483816 countsByYear W21584838162017 @default.
- W2158483816 countsByYear W21584838162018 @default.
- W2158483816 countsByYear W21584838162019 @default.
- W2158483816 countsByYear W21584838162020 @default.
- W2158483816 countsByYear W21584838162021 @default.
- W2158483816 countsByYear W21584838162022 @default.
- W2158483816 countsByYear W21584838162023 @default.
- W2158483816 crossrefType "journal-article" @default.
- W2158483816 hasAuthorship W2158483816A5005750354 @default.
- W2158483816 hasAuthorship W2158483816A5005760956 @default.
- W2158483816 hasAuthorship W2158483816A5021124944 @default.
- W2158483816 hasAuthorship W2158483816A5031327122 @default.
- W2158483816 hasAuthorship W2158483816A5035964802 @default.
- W2158483816 hasAuthorship W2158483816A5036839901 @default.
- W2158483816 hasAuthorship W2158483816A5038048953 @default.
- W2158483816 hasAuthorship W2158483816A5039765871 @default.
- W2158483816 hasAuthorship W2158483816A5066180617 @default.
- W2158483816 hasAuthorship W2158483816A5068291978 @default.
- W2158483816 hasAuthorship W2158483816A5069571779 @default.
- W2158483816 hasBestOaLocation W21584838161 @default.